Conversely, IFN-γ+ T cell population (about 6% of peripheral blood cells; without any stimulation in vitro) is expanded in T2D patients from the United States, while IL-17+ T cell population (only 0.3% of peripheral blood cells; without any stimulation in vitro) is not enhanced [39]. This evidence concerns the gene IL17A and type 2 diabetes mellitus.